Industry has been under increased pressure in both Europe and the U.S. to make public extensive detailed information collected during clinical trials, and the IOM advisors have produced a compromise approach that supports broad, routine data sharing, while also protecting the rights of multiple stakeholders. Data sharing is important for encouraging further research, supporting regulatory decisions, and increasing public trust in clinical research, said Bernard Lo, president of The Greenwall Foundation, who chaired the IOM committee. The main goal, he observed, is that the sharing of clinical trial data should become “the expected norm.”
Read more at source article: www.pharmaexec.com
A best friend is a reservoir of wisdom, offering insights garnered from their own experiences. They pass on knowledge that is often more valuable than any textbook. https://statusraja.in/friendship-whatsapp-status-video-download/